Alto Neuroscience Statistics
Total Valuation
ANRO has a market cap or net worth of $59.69 million. The enterprise value is -$90.10 million.
Important Dates
The next estimated earnings date is Tuesday, May 13, 2025, after market close.
| Earnings Date | May 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ANRO has 27.07 million shares outstanding. The number of shares has increased by 559.39% in one year.
| Current Share Class | 27.07M |
| Shares Outstanding | 27.07M |
| Shares Change (YoY) | +559.39% |
| Shares Change (QoQ) | -0.69% |
| Owned by Insiders (%) | 8.24% |
| Owned by Institutions (%) | 66.94% |
| Float | 19.50M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.40 |
| P/TBV Ratio | 0.40 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 16.92, with a Debt / Equity ratio of 0.11.
| Current Ratio | 16.92 |
| Quick Ratio | 16.81 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -49.90 |
Financial Efficiency
Return on equity (ROE) is -55.19% and return on invested capital (ROIC) is -34.37%.
| Return on Equity (ROE) | -55.19% |
| Return on Assets (ROA) | -32.46% |
| Return on Invested Capital (ROIC) | -34.37% |
| Return on Capital Employed (ROCE) | -40.95% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$808,303 |
| Employee Count | 76 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -83.75% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -83.75% |
| 50-Day Moving Average | 2.81 |
| 200-Day Moving Average | 7.07 |
| Relative Strength Index (RSI) | 44.73 |
| Average Volume (20 Days) | 330,431 |
Short Selling Information
The latest short interest is 3.69 million, so 13.63% of the outstanding shares have been sold short.
| Short Interest | 3.69M |
| Short Previous Month | 3.72M |
| Short % of Shares Out | 13.63% |
| Short % of Float | 18.92% |
| Short Ratio (days to cover) | 8.72 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -68.61M |
| Pretax Income | n/a |
| Net Income | -61.43M |
| EBITDA | -68.11M |
| EBIT | -68.61M |
| Earnings Per Share (EPS) | -$2.50 |
Full Income StatementBalance Sheet
The company has $168.23 million in cash and $16.94 million in debt, giving a net cash position of $151.29 million or $5.59 per share.
| Cash & Cash Equivalents | 168.23M |
| Total Debt | 16.94M |
| Net Cash | 151.29M |
| Net Cash Per Share | $5.59 |
| Equity (Book Value) | 151.46M |
| Book Value Per Share | 5.61 |
| Working Capital | 159.33M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$47.42 million and capital expenditures -$2.08 million, giving a free cash flow of -$49.50 million.
| Operating Cash Flow | -47.42M |
| Capital Expenditures | -2.08M |
| Free Cash Flow | -49.50M |
| FCF Per Share | -$1.83 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |